摘要
目的:比较中药参苓白术散与西药诺氟沙星治疗慢性肠炎的临床疗效。方法:收集100例确诊为慢性肠炎的患者,将其随机分为诺氟沙星治疗组(对照组)与参苓白术散治疗组(治疗组)。对照组口服诺氟沙星,治疗组口服参苓白术散加减,治疗两个疗程(10天为一疗程),采用统计学方法观察两组疗效与半年复发率。结果:对照组总有效率为84%,治疗组总有效率为92%,差异显著(P<0.05);对照组半年复发率为50%,治疗组半年复发率为10%,差异极显著(P<0.01)。结论:采用参苓白术散治疗慢性肠炎的临床疗效要优于诺氟沙星,且不易复发,建议在临床上优先选择参苓白术散治疗慢性肠炎。
Objective： To compare the clinical efficacy of shenlingbaizhu powder（Chinese medicine）with norfloxacinin the treat- ment of chronic enteritis. Methods： 100 patients who were diagnosed as chronic enteritis were divided into two groups randomly. One group, as control group, took norfloxacin orally. Another group, as treatment group, took shenlingbaizhu powder orally. They were both treated for two courses （10 days for a course of treatment）. Statistical methods were used to compare their curative effects and recurrence rate in halfa year. Results： The total effective rate of the control group was 84%, the total effective rate of the treatment group was 92%, and the difference between them was significant （P〈0.05）; The recurrence rate in halfa year of the control group was 50%, the recurrence rate in halfa year of the treatment group was 10%, and the difference between them was highly significant （P〈0.01）. Conclusion： The clinical efficacy of shenlingbaizhu powder in the treatment was better than norfloxacin, and it is not easy to relapse. So we insist that shenlingbaizhu powder was the optimization selection for the treatment of chronic enteritis.
出处
《现代生物医学进展》
CAS
2014年第20期3925-3927,3934,共4页
Progress in Modern Biomedicine
基金
国家自然科学基金项目(81100599)
关键词
参苓白术散
诺氟沙星
慢性肠炎
中西药临床疗效比较
Shenlingbaizhu powder
Norfloxacin
Chronicenteritis
Comparision of clinical efficacy between Chinese medicine and western medicine
